Efficacy and Safety of the Angiotensin Receptor Blocker Valsartan in Children With Hypertension Aged 1 to 5 Years-Reference-Cited by-同舟云学术

Efficacy and Safety of the Angiotensin Receptor Blocker Valsartan in Children With Hypertension Aged 1 to 5 Years

Published:2008-08 Issue:2 Volume:52 Page:222-228
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Flynn Joseph T.¹,Meyers Kevin E.C.¹,Neto Jose Pacheco¹,de Paula Meneses Rejane¹,Zurowska Aleksandra¹,Bagga Arvind¹,Mattheyse Lionel¹,Shi Victor¹,Gupte Jitendra¹,Solar-Yohay Susan¹,Han Guangyang¹

Affiliation:

1. From the Division of Nephrology (J.T.F.), Children’s Hospital and Regional Medical Center, Seattle, Wash; Division of Nephrology (K.E.C.M.), Children’s Hospital of Philadelphia, Pa; Department of Pediatrics (J.P.N.), Instituto Materno Infantil de Pernambuco, Recife, Pernambuco, Brazil; Centro de Nefrolog Ped do Parana-Hosp (R.d.P.M.), Curitibal, Brazil; Department of Pediatric and Adolescent Nephrology and Hypertension (A.Z.), Gdansk University Medical School, Gdansk, Poland; Department of...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference21 articles.

1. Successes and shortcomings of the food and drug modernization act

2. Pharmacologic treatment of hypertension in children and adolescents

3. McCrory WW. Definition prevalence and distribution of causes of hypertension. In: Loggie JMH ed. Pediatric and Adolescent Hypertension. Cambridge MA: Blackwell Scientific Publications; 1992: 104–111.

4. Etiology of sustained hypertension in children in the Southwestern United States

5. Hypertension in Children

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation, in-vitro evaluation and optimization of valsartan nano- lipid complex by Box-Behnken design;PAK J PHARM SCI;2023

2. Efficacy and Safety of Angiotensin Receptor Blockers in Pediatric Patients (Aged 6 to 18) with Hypertension: A Systematic Review;IRAN J KIDNEY DIS;2023

3. Changes in Drug Development Regulations and Their Impact on Clinical Trials;Pediatric Hypertension;2023

4. Post-Kidney Transplant Hypertension in Children;Pediatric Solid Organ Transplantation;2023

5. Narrative update of clinical trials with antihypertensive drugs in children and adolescents;Frontiers in Cardiovascular Medicine;2022-11-21